Drug Treatment Utilization Before, During and After Pregnancy

Overview

Journal J Subst Use

Publisher Informa Healthcare

Date 2012 Jun 22

PMID 22719224

Citations 5

Authors

Ellen L Wolfe

Joseph R Guydish

Ann Santos

Kevin L Delucchi

Alice Gleghorn

Affiliations

Soon will be listed here.

Abstract

This study retrospectively explored drug treatment utilization before, during and after pregnancy for all identified substance-using women delivering at a county hospital over a 4-year period (n=431). Drug treatment data were linked to hospital data to analyse treatment utilization. Fifty-three per cent received treatment the year before, during, or within the year after delivery, with a significantly higher proportion receiving treatment during and after pregnancy. There were significant increases in methadone and residential treatment services during pregnancy. Women spent significantly more time in treatment after delivery compared with before or during pregnancy. However, 47% of these women did not receive drug treatment. These findings support current literature suggesting that pregnancy presents an opportunity to engage women in treatment. However, there is a need to decrease the institutional, legal, and funding barriers that exist between health care and drug treatment providers. Utilizing available data to track perinatal substance use and treatment utilization are important to plan for adequate availability of treatment services for this population.

Citing Articles

Postpartum Treatment for Substance Use Disorder Among Mothers of Infants with Neonatal Abstinence Syndrome and Prenatal Substance Exposure.

Faherty L, Heins S, Kranz A, Stein B Womens Health Rep (New Rochelle). 2021; 2(1):163-172.

PMID: 34235503 PMC: 8243701. DOI: 10.1089/whr.2020.0128.

Assessment of Racial and Ethnic Disparities in the Use of Medication to Treat Opioid Use Disorder Among Pregnant Women in Massachusetts.

Schiff D, Nielsen T, Hoeppner B, Terplan M, Hansen H, Bernson D JAMA Netw Open. 2020; 3(5):e205734.

PMID: 32453384 PMC: 7251447. DOI: 10.1001/jamanetworkopen.2020.5734.

The Impact of the Opioid Epidemic on Children and Adolescents.

Winstanley E, Stover A Clin Ther. 2019; 41(9):1655-1662.

PMID: 31303278 PMC: 7017799. DOI: 10.1016/j.clinthera.2019.06.003.

Coordinating Outpatient Care for Pregnant and Postpartum Women with Opioid Use Disorder: Implications from the COACHH Program.

Hodgins F, Lang J, Malseptic G, Melby L, Connolly K Matern Child Health J. 2019; 23(5):585-591.

PMID: 30604105 DOI: 10.1007/s10995-018-2683-y.

Incentives for retention of pregnant substance users: a secondary analysis.

Brigham G, Winhusen T, Lewis D, Kropp F J Subst Abuse Treat. 2009; 38(1):90-5.

PMID: 19577405 PMC: 2789836. DOI: 10.1016/j.jsat.2009.05.005.

References

Guydish J, Moore L, Gleghorn A, Davis T, Sears C, Harcourt J . Drug abuse treatment on demand in San Francisco: preliminary findings. J Psychoactive Drugs. 2001; 32(4):363-70. DOI: 10.1080/02791072.2000.10400237. View

Kelly R, Zatzick D, Anders T . The detection and treatment of psychiatric disorders and substance use among pregnant women cared for in obstetrics. Am J Psychiatry. 2001; 158(2):213-9. DOI: 10.1176/appi.ajp.158.2.213. View

Chasnoff I, Landress H, Barrett M . The prevalence of illicit-drug or alcohol use during pregnancy and discrepancies in mandatory reporting in Pinellas County, Florida. N Engl J Med. 1990; 322(17):1202-6. DOI: 10.1056/NEJM199004263221706. View

HOWELL E, Chasnoff I . Perinatal substance abuse treatment. Findings from focus groups with clients and providers. J Subst Abuse Treat. 1999; 17(1-2):139-48. DOI: 10.1016/s0740-5472(98)00069-5. View

Vega W, Kolody B, Hwang J, Noble A . Prevalence and magnitude of perinatal substance exposures in California. N Engl J Med. 1993; 329(12):850-4. DOI: 10.1056/NEJM199309163291207. View

Birchfield M, Scully J, Handler A . Perinatal screening for illicit drugs: policies in hospitals in a large metropolitan area. J Perinatol. 1995; 15(3):208-14. View

Grella C . Women in residential drug treatment: differences by program type and pregnancy. J Health Care Poor Underserved. 1999; 10(2):216-29. DOI: 10.1353/hpu.2010.0174. View

Lester B, Andreozzi L, Appiah L . Substance use during pregnancy: time for policy to catch up with research. Harm Reduct J. 2004; 1(1):5. PMC: 419718. DOI: 10.1186/1477-7517-1-5. View

Marsh J, DAunno T, Smith B . Increasing access and providing social services to improve drug abuse treatment for women with children. Addiction. 2000; 95(8):1237-47. DOI: 10.1046/j.1360-0443.2000.958123710.x. View

10.

Chavkin W . Drug addiction and pregnancy: policy crossroads. Am J Public Health. 1990; 80(4):483-7. PMC: 1404583. DOI: 10.2105/ajph.80.4.483. View

11.

HOWELL E, Heiser N, Harrington M . A review of recent findings on substance abuse treatment for pregnant women. J Subst Abuse Treat. 1999; 16(3):195-219. DOI: 10.1016/s0740-5472(98)00032-4. View

12.

Saitz R, Mulvey K, Plough A, Samet J . Physician unawareness of serious substance abuse. Am J Drug Alcohol Abuse. 1997; 23(3):343-54. DOI: 10.3109/00952999709016881. View

13.

SIMPSON D . Treatment for drug abuse. Follow-up outcomes and length of time spent. Arch Gen Psychiatry. 1981; 38(8):875-80. DOI: 10.1001/archpsyc.1981.01780330033003. View

14.

Breitbart V, Chavkin W, Wise P . The accessibility of drug treatment for pregnant women: a survey of programs in five cities. Am J Public Health. 1994; 84(10):1658-61. PMC: 1615077. DOI: 10.2105/ajph.84.10.1658. View

15.

Samet J, Rollnick S, Barnes H . Beyond CAGE. A brief clinical approach after detection of substance abuse. Arch Intern Med. 1996; 156(20):2287-93. DOI: 10.1001/archinte.156.20.2287. View

16.

Lester B, ElSohly M, Wright L, Smeriglio V, Verter J, Bauer C . The Maternal Lifestyle Study: drug use by meconium toxicology and maternal self-report. Pediatrics. 2001; 107(2):309-17. DOI: 10.1542/peds.107.2.309. View

17.

Zellman G, Fair C, Hoube J, Wong M . A search for guidance: examining prenatal substance exposure protocols. Matern Child Health J. 2002; 6(3):205-12. DOI: 10.1023/a:1019734314414. View

18.

Eisen M, Dampeer J, Sambrano S . Evaluation of substance use outcomes in demonstration projects for pregnant and postpartum women and their infants: findings from a quasi-experiment. Addict Behav. 2000; 25(1):123-9. DOI: 10.1016/s0306-4603(98)00116-6. View

19.

Klein D, Zahnd E . Perspectives of pregnant substance-using women: findings from the California Perinatal Needs Assessment. J Psychoactive Drugs. 1997; 29(1):55-66. DOI: 10.1080/02791072.1997.10400170. View

20.

Gehshan S . Missed opportunities for intervening in the lives of pregnant women addicted to alcohol or other drugs. J Am Med Womens Assoc (1972). 1995; 50(5):160-3. View